ArticleOncoimmunology2022

Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells.

Niels Werchau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.